These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24915850)

  • 1. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.
    Hubers AJ; Brinkman P; Boksem RJ; Rhodius RJ; Witte BI; Zwinderman AH; Heideman DA; Duin S; Koning R; Steenbergen RD; Snijders PJ; Smit EF; Sterk PJ; Thunnissen E
    J Clin Pathol; 2014 Aug; 67(8):707-11. PubMed ID: 24915850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.
    Hubers AJ; Heideman DA; Burgers SA; Herder GJ; Sterk PJ; Rhodius RJ; Smit HJ; Krouwels F; Welling A; Witte BI; Duin S; Koning R; Comans EF; Steenbergen RD; Postmus PE; Meijer GA; Snijders PJ; Smit EF; Thunnissen E
    Br J Cancer; 2015 Mar; 112(6):1105-13. PubMed ID: 25719833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
    Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
    J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation analysis in spontaneous sputum for lung cancer diagnosis.
    Hubers AJ; van der Drift MA; Prinsen CF; Witte BI; Wang Y; Shivapurkar N; Stastny V; Bolijn AS; Hol BE; Feng Z; Dekhuijzen PN; Gazdar AF; Thunnissen E
    Lung Cancer; 2014 May; 84(2):127-33. PubMed ID: 24598366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.
    Hubers AJ; Heideman DA; Herder GJ; Burgers SA; Sterk PJ; Kunst PW; Smit HJ; Postmus PE; Witte BI; Duin S; Snijders PJ; Smit EF; Thunnissen E
    J Clin Pathol; 2012 Jun; 65(6):541-5. PubMed ID: 22461647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
    Su Y; Fang H; Jiang F
    Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
    Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
    Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
    Zhang Z; Yan S; Cui H; Chen H; Liu J
    Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
    Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
    de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
    J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
    Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
    Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
    Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular sputum analysis for the diagnosis of lung cancer.
    Hubers AJ; Prinsen CF; Sozzi G; Witte BI; Thunnissen E
    Br J Cancer; 2013 Aug; 109(3):530-7. PubMed ID: 23868001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
    Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
    Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
    [No Abstract]   [Full Text] [Related]  

  • 16. An epigenetic classifier for early stage lung cancer.
    Su Y; Fang HB; Jiang F
    Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.
    Han W; Wang T; Reilly AA; Keller SM; Spivack SD
    Respir Res; 2009 Sep; 10(1):86. PubMed ID: 19781081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
    Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraction and characterization of exosomes from the exhaled breath condensate and sputum of lung cancer patients and vulnerable tobacco consumers-potential noninvasive diagnostic biomarker source.
    Bano A; Yadav P; Sharma M; Verma D; Vats R; Chaudhry D; Kumar P; Bhardwaj R
    J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38988301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostic markers for lung cancer in sputum and plasma.
    Wang YC; Hsu HS; Chen TP; Chen JT
    Ann N Y Acad Sci; 2006 Sep; 1075():179-84. PubMed ID: 17108209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.